Advances in recombinant protein expression for use in pharmaceutical research. | Curr Opin Struct Biol;23(3): 393-402, 2013 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Advances in recombinant protein expression for use in pharmaceutical research.

Assenberg, Rene; Wan, Paul T; Geisse, Sabine; Mayr, Lorenz M.

Affiliation

Assenberg R; Novartis Pharma AG, Expertise Platform Proteases, Fabrikstrasse-16, Basel CH-4002, Switzerland.

Curr Opin Struct Biol ; 23(3): 393-402, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23731801

Subject(s)

Drug Discovery; Recombinant Proteins/biosynthesis; Baculoviridae; Cells, Cultured; Escherichia coli; Gene Expression; Genetic Vectors; Recombinant Proteins/genetics; Recombinant Proteins/metabolism; Staining and Labeling; Transfection

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Drug Discovery Language: En Journal: Curr Opin Struct Biol Journal subject: BIOLOGIA MOLECULAR Year: 2013 Type: Article Affiliation country: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Drug Discovery Language: En Journal: Curr Opin Struct Biol Journal subject: BIOLOGIA MOLECULAR Year: 2013 Type: Article Affiliation country: Switzerland